Scabies Control in European Refugee Camps Collided With Sanitation Gaps and Weak Coordination
Healthcare staff working in refugee and migrant camps across Europe described a pattern of scabies management shaped less by clinical choice than by the conditions around it. In camps where overcrowding, limited washing facilities, and unstable staffing were routine, diagnosis often depended on bedside judgment alone, and treatment varied widely from one site to another. The result was a fragmented response to a disease that spreads easily through close contact and is notoriously difficult to control when hygiene infrastructure is poor.
This retrospective qualitative study drew on semistructured telephone interviews with 12 healthcare workers who had treated scabies or managed outbreaks in formal and informal camps across 15 locations in seven European countries. The participants included doctors, nurses, allied health workers, and one medical student, reflecting the improvised workforce that often supports care in these settings. Their accounts point to a problem that is both medical and operational: scabies is treatable, but treatment is hard to deliver when the setting itself drives reinfection.
One sentence captures the clinical impasse: diagnosis was usually visual, not instrumented, and treatment pathways were inconsistent.
Bedside Diagnosis Without Dermatoscopy Shaped the Response
Across the camps described, scabies diagnosis was primarily clinical, and dermatoscopy was not part of routine practice. In a stable outpatient setting, that may still be workable when the eruption is classic and the clinician is experienced. In camp medicine, the margin for error is much smaller. Skin conditions can overlap, staff may be unfamiliar with parasitic infestations, and privacy for examination may be limited. Under those conditions, certainty is difficult, and uncertainty can delay treatment or lead to variable prescribing patterns.
Seven participants said scabicides were available. Five said only symptomatic treatment was offered. That divide matters because symptomatic care alone does not remove mites or interrupt transmission, especially when people are living in shared quarters and sleeping close together. For a condition with high household or contact spread, incomplete treatment becomes a practical driver of repeated outbreaks. The biology is straightforward: the parasite survives by moving through human contact, and every untreated contact chain extends the outbreak.
Water, Sanitation, and Hygiene Were the Core Barrier
The most consistent obstacle described by staff was the lack of water, sanitation, and hygiene infrastructure. Absence or limitation of showers made it difficult to wash off topical scabicides. Inability to wash clothes and bedding likely increased transmission and reinfestation. These are not minor inconveniences; they are central to whether standard treatment can work at all.
Scabies management relies on more than applying a cream or taking a dose of medicine. Clothing, bedding, and close living conditions all influence whether treatment succeeds. When those supports are missing, a correctly chosen drug can still fail in practice. In that sense, the camp environment can nullify a biologic intervention that would be effective in ordinary housing.
Stigma, Mobility, and Language Fractured Follow-up
Social barriers also shaped the outbreak response. Staff described language differences, stigma, treatment non-compliance, and frequent movement within or between sites. Each of these can obstruct contact tracing and make repeat treatment difficult. Stigma is especially damaging in crowded settlements, where a visible skin condition may already carry social judgment. If people avoid care, hide symptoms, or disengage after one encounter, the chain of transmission remains intact.
Mobility created a second problem: follow-up treatments are harder when residents move before the next dose or review can be arranged. For outbreaks that require coordinated action across contacts, even short gaps in continuity can undermine control efforts. In these camps, the standard assumptions of ambulatory care did not hold.
Staffing Shortages and Organizational Friction Undercut Treatment Delivery
Healthcare-related barriers were just as important. Participants described scabicide shortages and diversity, a lack of examination privacy, and inexperience among staff. When the available medications vary from site to site, protocols become harder to standardize. When staff turnover is high and experience is limited, diagnosis and treatment decisions may differ from one clinician to the next. Privacy deficits also matter because skin assessment requires direct examination, and patients may be reluctant to disclose symptoms or allow close inspection when basic dignity is compromised.
The organizational problems were equally stark. Overcrowding intensified transmission risk. Poor coordination between organizations slowed response. Some participants also described lack of support and maltreatment by state authorities, including failure to provide basic facilities, obstruction of self-care by camp residents, and interference with NGO aid. In that context, outbreak control became dependent on small volunteer-led groups trying to compensate for systemic neglect.
A treatment protocol cannot compensate for a camp that makes infection easy and care difficult.
Oral Ivermectin and Practical Guidance Emerge as the Most Realistic Path
The study ends with a clear recommendation: accessible scabies guidelines for camps, consensus diagnostic criteria, and oral ivermectin mass treatment. Those proposals fit the realities described by staff. Where topical treatment is hard to complete because showers, laundry access, and privacy are limited, an oral strategy can be more feasible at scale. Mass treatment also makes sense when contact tracing is undermined by mobility and when outbreaks involve crowded living arrangements rather than isolated households.
The appeal of consensus criteria is equally practical. In settings where dermatoscopy is unavailable and clinicians come from different backgrounds, standardized diagnostic guidance could reduce variation in who gets treated and when. Clearer criteria would not solve the structural problems on their own, but they could reduce one source of inconsistency in already strained settings.
What Camp Medicine Still Lacks
This study is qualitative, and its strength lies in the clinical texture of staff experience rather than in numerical estimates of outbreak size or treatment effect. The interviews reveal how scabies control breaks down when infrastructure, staffing, and governance fail together. They also show how dependent outbreak care in refugee and migrant camps can be on small, volunteer-staffed nongovernmental teams working with limited support.
For clinicians and health systems, the message is concrete. Scabies in camps is not only a dermatologic problem; it is a test of whether basic care can function in environments where water is scarce, people move frequently, and coordination is fragile. The next step is not merely better medication access, but guidance and delivery systems designed for places where standard outpatient assumptions no longer apply.